Therapeutics Hormonal Agents

Oestriol in the prophylactic treatment of recurrent urinary tract infections in postmenopausal women

Kirkengen AL, Andersen P, Gjersøe E, Johannessen GR, Johnsen N, Bodd E

Published June 1992 Scandinavian Journal of Primary Health Care, 10(2), 139-142
DOI 10.3109/02813439209014051 PMID 1641524

Abstract

A block randomized, double-blind, group-comparative, placebo-controlled study was conducted to assess the effect of oestriol on recurrent urinary tract infections in postmenopausal women. 40 women, median age 78 years (66-91), 20 in each group, were treated with oestriol three mg p.o. per day or corresponding placebo for four weeks, followed by one mg per day for eight weeks. The main response parameter was the number of urinary tract infections per week in the two treatment periods. Both oestriol and placebo reduced the number of infections per week significantly in both periods, compared with the pretreatment period. There was no difference between oestriol and placebo treatment in the first period. In the second period, however, oestriol treatment was significantly more effective than placebo (p = 0.05). Correspondingly, there was a significant difference between the two groups in the vaginal pH at the end of the study (p less than 0.05). We conclude that oestriol reduces recurrent urinary tract infections in postmenopausal women.

Topics

Related research

Therapeutics › Hormonal Agents › Estrogen Preparations · General Gynecology › Infections › Vaginal and Cervical Infections · Perimenopause and Menopause › Hormone Therapy › Benefits and Risks
Anne Luise Kirkengen, Per Andersen, Einar Gjersøe, Grethe Riis Johannessen, Nils Johnsen, Egil Bodd
A Kirkengen, P Andersen, E Gjersøe, G Johannessen, N Johnsen, E Bodd
PMID 1641524 1641524 DOI 10.3109/02813439209014051 10.3109/02813439209014051 Kirkengen et al. 1992, Kirkengen 1992